What Is Hexarelin? Benefits, Research & Safety

Hexarelin was developed as part of ongoing research into growth hormone secretagogues following the initial discovery of GHRPs in the 1980s. It was designed to be a potent and stable GH-releasing peptide based on structure-activity relationship studies. Preclinical research revealed that Hexarelin was among the most potent GHRPs, producing significant GH release. Clinical trials were conducted for potential use in GH deficiency and other conditions. Research also identified Hexarelin's cardioprotective properties, which generated interest in potential cardiovascular applications. Studies showed beneficial effects on ischemia-reperfusion injury and cardiac function. However, clinical development did not result in regulatory approval. One limitation identified was the development of desensitisation with repeated administration—the GH-releasing effect appeared to diminish over time, potentially limiting long-term therapeutic utility. Hexarelin remains an important research tool and continues to be studied, particularly for its cardiac effects.